Slated to open in 2022, the site will complement production sites and centres in Asia, Europe, India, Mexico and North America.
Phillips-Medisize, a Molex company and provider of drug delivery, diagnostic and MedTech devices, has announced the expansion of its global manufacturing footprint, along with extended product design, development and manufacturing capabilities. The company’s global reach now encompasses 36 facilities with end-to-end capabilities.
To address growing demand from customers in continental Europe, the company is building a medical manufacturing facility in Katowice, Poland.
“As the preferred partner for leading global customers, we continually invest in new talent and technologies that increase the capacity and capabilities of Phillips-Medisize across the entire value chain,” said Paul Chaffin, President, Medical and Pharmaceutical Solutions, Molex.